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The Joint Center for Structural Genomics high-throughput structural biology
pipeline has delivered more than 1000 structures to the community over the past
ten years. The JCSG has made a significant contribution to the overall goal of
the NIH Protein Structure Initiative (PSI) of expanding structural coverage of
the protein universe, as well as making substantial inroads into structural
coverage of an entire organism. Targets are processed through an extensive
combination of bioinformatics and biophysical analyses to efficiently char-
acterize and optimize each target prior to selection for structure determination.
The pipeline uses parallel processing methods at almost every step in the process
and can adapt to a wide range of protein targets from bacterial to human.
The construction, expansion and optimization of the JCSG gene-to-structure
pipeline over the years have resulted in many technological and methodological
advances and developments. The vast number of targets and the enormous
amounts of associated data processed through the multiple stages of the
experimental pipeline required the development of variety of valuable resources
that, wherever feasible, have been converted to free-access web-based tools and
applications.
1. Structural genomics: evolution of structural biology
The landscape of structural biology has changed dramatically during
the past decade. At the turn of this century, technological advances
broadened the application of structural biology to a much larger
audience by increasing the number and the complexity of specific
biological problems that could be addressed. This evolution in
molecular biology, which resulted from major improvements in
cloning, protein expression in heterologous systems, such as Escher-
ichia coli, and protein purification by affinity chromatography, has
significantly increased our ability to obtain the microgram to milli-
gram quantities of protein needed for structure determination by
X-ray crystallography or NMR. Combined with genetic manipulation
and engineering to facilitate heavy-atom integration into the target of
interest, these developments greatly increased the range of proteins
accessible to X-ray and NMR structure determination. Major
technological improvements in X-ray crystallography have signifi-
cantly increased the resolution, speed and quality of data collection
and structure determination. These developments included improved
crystallization screening methods that enhanced our ability to obtain
and optimize protein crystals, cryocooling techniques to obtain better
quality data from single crystals and increased brightness, stability,
availability and ‘user-friendliness’ of synchrotron and other X-ray
sources. Together, these advances greatly enhanced the quality of
data collection and extended it to smaller and smaller crystals. In
parallel, advances in the ‘dry lab’, such as continued development and
improvement of crystallographic and bioinformatics software
packages, have increased the speed, reliability and quality of struc-
ture determination. Although it was clear that significant progress
was being made in structural biology, it still paled in comparison to
the escalating numbers of new protein sequences that were being
generated by the worldwide DNA-sequencing efforts, such as the
human genome project.
2. The Protein Structure Initiative
Exploration in to the concept of high-throughput (HT) protein-
structure determination coincided with the dawn of the genomic era
in biology. The enormous success of DNA-sequencing technology,
followed by the development of other HT technologies, allowed
biology to extend its molecular perspective to the level of entire
organisms. These breakthroughs prompted global efforts into serious
consideration of the feasibility of HT protein-structure determina-
tion, which included the establishment of pilot projects in the USA,
Europe and Asia (Stevens et al., 2001). In the USA, the NIGMS
Protein Structure Initiative (PSI; http://www.nigms.nih.gov/Initiatives/
PSI/) played a decisive role in embracing this new challenge in a
timely way. The main scientific goal put forth by the PSI was to
determine atomic level structures of most proteins readily obtainable
from knowledge of their corresponding DNA sequences. Thus,
structural biologists were enabled to broaden their focus from
studying biological molecules one at a time and to a wider exploration
of the rapidly expanding protein-sequence universe, thereby
addressing questions on a genome scale. This new view of structural
biology was, therefore, called structural genomics and added new
perspectives and directions to the field (Stevens et al., 2001).
A technological revolution in structural biology then followed,
which was in a large part propelled by the new worldwide structural
genomics initiatives. Some might argue that this evolution would have
happened in the absence of structural genomics, but there is no
denying that these high-throughput initiatives had a significant
impact on the field and greatly facilitated progress by creating large
focused groups that could simultaneously optimize the myriad of
complex steps in the structure-determination process. Assembling the
initial gene-to-structure pipelines was rather challenging, but major
advances and developments in technology, automation and method-
ology were realised during the course of PSI-1 (2000–2005). The
lessons gleaned from these efforts then enabled the assembly of
high-throughput structural biology pipelines that developed into the
Large-Scale Production (LSP) Centers in PSI-2 (2005–2010; Burley et
al., 2008) and provided the foundation for the PSI Network (http://
www.sbkb.org/KB/psi_centers.html; http://www.nigms.nih.gov/Initiatives/
PSI/Centers). The PSI-2 centers embraced the concept of broad
structural coverage of protein-sequence space and vigorously
pursued this goal by judicious and highly coordinated target selection
that focused on selecting protein sequences that represented large
families with little or no structural coverage and then leveraging the
resulting experimental structures by homology modeling to cover
other memebers of the protein family (Fig. 1).
During this period, the four LSP Centers expended the majority
(70%) of their effort on these PSI Network targets. However, a
significant effort (30%) was also committed to targets nominated by
the broader research community and to specific biological/biomedical
themes selected by each Center. As a result, the LSP Centers
expanded and tailored their experimental and computational plat-
forms to tackle a wide diversity of protein types and classes using
a multitude of approaches, technologies and tools. They thereby
identified a number of bottlenecks in the HT process for which
solutions were achieved, thus opening new routes for solving the
structures of many targets that had previously presented seemingly
insurmountable obstacles. The six Specialized Centers in PSI-2 also
continued the PSI tradition of developing innovative methods,
approaches and technologies for protein production and structure
determination of macromolecules and complexes that are considered
to be highly challenging by the scientific community. The PSI
Materials Repository (PSI-MR) and the PSI/Nature Structural
Genomics Knowledgebase (PSI-SGKB), now called PSI-SBKB in
PSI:Biology were established in the latter half of PSI-2 in order to
gather the valuable products of the PSI Centers and make them
structural communications
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Figure 1
PSI Network strategy for structural genomics. In PSI-2, a network of research and resource centers were assembled in order to address its central mission of structural
coverage of unexplored regions of protein-sequence space. Achieving a better understanding of the relationships between protein sequence and structure represents a
critically important challenge to address the PSI’s principal goal of making structural information of most proteins readily available from knowledge of their corresponding
gene sequences.
available to the general scientific community, and two Modeling
Centers were formed to complete the PSI Network (http://
www.nigms.nih.gov/Initiatives/PSI/Centers).
Collectively, the PSI Centers have accumulated a high level of
expertise and knowhow in all steps from target selection to structure
determination, developing pipelines that can be applied to many
systems and to different classes of challenging proteins (Burley et al.,
2008). Many areas of science have already benefited significantly
from the output of the LSP, as well from the methods and technol-
ogies developed by the Specialized Centers. Thus, the PSI has
accelerated a wide range of basic research programs and provided
new ideas and applications for the biomedical sciences. The critical
mass of structural data generated by the PSI centers has also
advanced our understanding of many biological processes. Going far
beyond structure determination, the hundreds of thousands of
reagents generated in the PSI are available through the PSI-MR for
functional and mechanistic studies by the entire community.
The PSI is now entering its third phase as PSI:Biology, where
investigators will apply this new paradigm of high-throughput struc-
ture determination to study a broad range of challenging biological
and biomedical problems (http://www.nigms.nih.gov/Initiatives/PSI/
psi_biology). The majority of the targets for structure determination
will be defined through consortium partnership proposals that are
vetted by peer review through the NIH grant system and via an open
on-going community nomination process administered through the
PSI-SBKB. Additional targets will be defined through the individual
biological and biomedical theme projects of the LSP centers.
3. The JCSG: a scalable HT structural biology pipeline
producing over 200 novel structures per year
3.1. Pilot phase
The Joint Center for Structural Genomics (JCSG; http://
www.jcsg.org) was initiated in 1999 while the concepts of HT struc-
tural biology (HTSB) and structural genomics centers were still being
formulated. At that time, most tasks associated with structure
determination were highly labor-intensive, costly and could not be
scaled to a genomic level without a substantial influx of resources and
funding. The JCSG was established in 2000 as one of nine pilot
centers under the auspices of the NIGMS PSI to evaluate the feasi-
bility of assembling HT pipelines for protein-structure determination.
The primary mission of the JCSG was to establish a robust and
scalable HT structural biology pipeline and to assess its capability as a
foundation for establishing production centers in PSI-2. The design,
assembly and implementation of the JCSG pipeline was based on
three scientific cores, each specializing in specific components of the
gene-to-structure process: the BioInformatics Core (BIC; target
selection and structure annotation), the Crystallomics Core (CC;
cloning, protein production and crystallization) and the Structure
Determination Core (SDC; crystal screening and structure determi-
nation). The assembly of these pipelines came from developing
integrated and innovative technologies, methods and robotic plat-
forms to circumvent bottlenecks in traditional structural biology. Our
pipeline concept used a multi-tiered target-processing strategy that
efficiently incorporated the multiple steps from target selection to
structure deposition (Lesley et al., 2002). The integration of these
steps into a fully functional pipeline and its subsequent testing on the
first screen of an entire genome (Thermotoga maritima; TM) stands
as a unique accomplishment of the JCSG in PSI-1. The wide diversity
of TM targets processed through the pipeline established success
rates for individual steps in the process and enabled us to more
reliably predict the outcome for each stage (Lesley et al., 2002). The
JCSG evolved to work effectively as a highly integrated team focused
on the success of the overall pipeline and not just on its individual
steps or components. Thus, over the course of PSI-1, the JCSG
developed a fully integrated, scalable and high-output structural
genomics pipeline which addressed both prokaryotic and eukaryotic
targets (Fig. 2), including the incorporation of NMR as a pilot project
to investigate the feasibility of equivalent high-throughput NMR
structural communications
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Figure 2
JCSG high-throughput structural biology pipeline. A linear representation is shown, highlighting the typical flow of targets through the multiple processing stages in the
JCSG pipeline. The pipeline is subdivided into four main processing stages: (i) target selection, (ii) protein production and biophysical analysis, (iii) structure determination
and (iv) structure analysis, annotation and distribution to public databases.
approaches (Wu¨thrich, 2010). The pipeline currently utilizes X-ray
structure determination for the majority of targets, whereas the NMR
resources are reserved for targets that are not readily amenable to
X-ray structure determination, in addition to providing supplemen-
tary data such as screening protein stability and ligand binding.
3.2. Evolution of the HT pipeline
The JCSG developed its HTSB pipeline in PSI-1 with an emphasis
on scalability and adaptability that was driven by process data,
basically demonstrating that executing an effective HTSB workflow is
feasible. At the end of PSI-1, the JCSG was already producing 100
novel structures per year. In PSI-2, the LSP Centers were given a
tripartite challenge to maximize output, minimize cost and greatly
expand target diversity. The bar was also raised on the degree of
difficulty of targets; proteins previously regarded as challenging in
PSI-1 are now considered relatively routine. In PSI-2, the JCSG
implemented HTSB on a production scale and further modified and
extended it to reflect new production goals by anticipating challenges,
by developing and adapting new technologies and by modifying
workflow and resource allocations. The JCSG evolved to concomi-
tantly increase pipeline efficiency, ramp up capacity and expand reach
and, at the same time, significantly reduce operational costs
compared to PSI-1. Midway through PSI-2, the JCSG had already
significantly increased productivity and efficiency to achieve >200
structures per year while maintaining a high level of structural
novelty. This success was mainly achieved from cumulative syner-
gistically designed increases in efficiency at every stage, including
more rational target selection that identified potentially problematic
targets prior to the experimental stages. Small-scale bio-analytical
screening of constructs, optimized structure solution, model building
and validation, and the development of salvage pathways contributed
to this increase in productivity and also increased the success with
challenging targets (Fig. 3). Thus, the JCSG, along with the other LSP
Centers, clearly demonstrated that parallel processing, miniaturiza-
tion, statistical process analysis, standardization, efficient manage-
ment structures, open data access and focused technology
development can, indeed, be applied to front-line biological
problems. Many of these principles and technologies have now been
adopted worldwide, establishing their successful transfer to the
community as a highly beneficial and influential outcome of the PSI.
While the PSI centers, including the JCSG, have not necessarily
always been the initial inventors of some of the technologies or
methodologies, they have demonstrated their general utility by
further developing them and applying them to a very large number of
targets so that meaningful statistics are now available on the success
or failure of given methods, consequently offsetting the myriad of
anecdotal stories that often have little predictive value. Thus, in
developing our current pipeline, we tested experimental dogma and
anecdotal truths, replacing them with well defined, reliable and well
documented methods based on the analysis of thousands to tens of
thousands of samples. These methods were then implemented as
standardized HT approaches based on efficiency analyses. Our
technology and innovation have been highly geared towards pipeline
applicability and flexibility derived from cost/benefit analysis. For
example, when it was determined that neither conventional
restriction-enzyme cloning strategies nor newer ones, such as
recombinatorial cloning, could meet our budget constraints and we
needed to alter and insert DNA sequences with complete flexibility,
the JCSG developed PIPE cloning (Klock et al., 2008). This advance
permitted the insertion or modification of genes in virtually any
vector system with complete flexibility. Table 1 lists some other
important parameters for the successful development of the JCSG
Crystallomics pipeline during PSI-1 and PSI-2. The JCSG has
recently embarked on the next phase, PSI:Biology, in which the
technologies and methods developed and refined during the previous
phase will be applied to challenging biological systems in association
with our PSI:Biology partner centers.
3.3. HT pipeline
Parallel processing and data capture is a primary driver of the
JCSG pipeline and is incorporated into all stages of the process
structural communications
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Table 1
JCSG pipeline economic drivers.
Parameter Impact (related publication)
Nanovolume crystallization Significant reduction in the quantity of protein and
reagents per screen; faster results (Weselak et al.,
2003; Santarsiero et al., 2002)
PIPE cloning (Klock et al., 2008; Spraggon et al., 2004a)
Orthologs, mutations, truncations (Klock et al., 2008; Spraggon et al., 2004b, 2005)
Optimized crystal screens Minimal conditions to screen (Page et al., 2003)
Parallel processing Unit cost reduction, efficient workflow (DiDonato
et al., 2004; Lesley et al., 2002)
Optimized salvage Increased output at minimal cost
Automation Speed, consistency, decreased FTE costs (Lesley et
al., 2002; McPhillips et al., 2002; Wolf et al., 2005;
Weselak et al., 2003; Soltis et al., 2008)
Smart target selection Increased per target success rate (Slabinski,
Jaroszewski, Rodrigues et al., 2007), genome pool
strategy (Jaroszewski et al., 2008)
Figure 3
Evolution of main pipeline workflow. Flowchart of the current JCSG HTSB
pipeline highlighting feedback loops and salvage pathways for recalcitrant targets.
(Fig. 4). Targets enter the pipeline either from the PSI Network, our
own biomedical/biological theme projects or from the community and
are subjected to computational filters that estimate the probability of
success of a given target. Each target then proceeds to the cloning
stage, accompanied by a set of complementary homologs and/or
constructs, resulting in multiple, full-length clones or truncated
constructs, with the goal of increasing our chance of success in later
stages. Each of these constructs is then evaluated by microexpression,
which produces sufficient protein for extensive biophysical char-
acterization, yielding an experimental estimate of the likelihood of
crystallization success. Thus, the pipeline efficiently produces vast
collections and varieties of proteins for crystallization trials that
result in an equally impressive number of crystals to screen for the
best diffracting samples. High-quality diffraction data enable struc-
tures to be refined and validated to exacting specifications before
deposition in the PDB, with independent, internal, quality-control
procedures designed to maintain a uniformly high quality of the
deposited structures. Vectors and clones are deposited with the PSI-
MR and resources, methods, analyses etc. are entered into the PSI-
SBKB. Targets are tracked from start to finish in the internal tracking
database available through the JCSG website (http://www.jcsg.org),
with the most pertinent information exported to TargetDB (http://
targetdb.pdb.org). Finally, information on all experimental protocols
is deposited in PepcDB (http://pepcdb.pdb.org), and TOPSAN
(Krishna et al., 2010; Weekes et al., 2010) pages provide public access
and outreach to the multiple diverse analyses on this enormous
resource of protein structures.
4. Concluding remarks
Structural genomics is now established as a field that is making major
contributions to our knowledge of the protein-sequence universe
(Nair et al., 2009). The genome-sequencing efforts have provided
structural genomics with unheralded opportunities to explore the
richness and diversity of life forms and the fundamental processes
that allow organisms to evolve and function in their own niches and
environments. The development of HT platforms from target selec-
tion to structure determination has enabled structural genomics to
embrace these new exciting challenges and opportunities. As we
move forward into PSI:Biology, we will explore how these efficient
and highly productive HT pipelines can be harnessed not only to
tackle some of the most prescient and topical problems in the
biological and biomedical sciences, but also to create exciting new
research areas for future generations of scientists. Many possible
strategies employing the HTSB technologies and platforms can be
envisioned, ranging from general exploration of the expanding
protein universe to more focused forays into individual organisms,
protein networks, pathways or specific families of proteins.
This special JCSG issue ofActa Crystallographica Section F aims to
give a flavor of the type and range of projects that we have been
working on over the last few years and illustrates some of the insights
that can be gained from structural genomics. The JCSG has recently
passed the 1000-structure milestone, where the majority of the
structures are novel (>80%) as defined by a less than 30% sequence
identity of the JCSG structure to any other structure in the PDB at
the time of deposition. The structures deposited range from bacterial
to human proteins, although the vast majority are of bacterial origin,
since these were the ones on which the pipeline was assembled and
tested. The large numbers of targets and the enormous amounts of
associated data collected and processed through the multiple stages
of our experimental pipeline have resulted in the development of
innovative methods and tools at critical stages in our gene-to-struc-
ture pipeline. These resources, where feasible, have been converted
to free-access web-based tools and applications that include XtalPred
(http://
ffas.burnham.org/XtalPred; Slabinski, Jaroszewski, Rychlewski et al.,
2007), Quality Control (http://smb.slac.stanford.edu/jcsg/QC) and
Ligand Search (http://smb.slac.stanford.edu/jcsg/Ligand_Search;
Kumar et al., 2010) servers and TOPSAN (http://www.topsan.org;
Krishna et al., 2010; Weekes et al., 2010), as well as other tools and
resources available on our website (http://www.jcsg.org). In parti-
cular, the JCSG maintains a crystallographic data-set repository that
contains all files from all stages of the structure-solution process,
structural communications
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Figure 4
JCSG PSI-2 production pipeline and underlying data-handling architecture. The JCSG large-scale production center integrates custom and commercial instrumentation into
the highly parallelized HTSB pipeline. Data capture from >500 parameters encompassing over 30 stages are captured to a centralized database via the JCSG tracking
database that parallels the experimental pipeline. Data flow back to the experimental pipeline provides feedback for target and pipeline management and smart target
selection.
including a full set of diffraction images for each of our deposited
structures, enabling complete reconstruction of the data processing
(http://www.jcsg.org/datasets-info.shtml). The repository has been
used by numerous prominent crystallographic software developers to
assist in testing new algorithms (Yao et al., 2006; Cowtan, 2008;
Panjikar et al., 2009; Sauter & Zwart, 2009; Skuba´k et al., 2009;
Terwilliger et al., 2009; Winter, 2005) and has also been used for
benchmarking (Joosten et al., 2009) and teaching (Faust et al., 2008).
Individual data sets can also be downloaded directly from the
JCSG structure gallery (http://www.jcsg.org/prod/newscripts/
structure_gallery/gallery.cgi). The repository currently has 72 regis-
tered users, many of whom are students or postdocs who are keen to
have access to data sets to advance their knowledge of X-ray crys-
tallography. The repository is freely available to the scientific
community and will be maintained and extended in PSI:Biology. We
understand that such resources are of high value to the general
scientific community and we welcome any feedback and comments on
how to improve their utility.
As we move forward, the goal is to continue to push the limits of
what can be accomplished in structural biology and to ensure that the
methods, technologies and automation that have been and are being
developed are transferable to individual laboratories (Gra¨slund et al.,
2008). Many of the advances at synchrotron beamlines have occurred
in partnership with Structural Genomic centers and likewise many of
the available crystallization robots and protein expression and puri-
fication devices and platforms, as well as software packages and tools,
have their origin in the PSI and other SG centers. The following
articles give a tantalizing glimpse of the exciting possibilities for the
future, but also highlight the need to ensure that concomitant
advances in other basic tools are also realised in order to enable
exploration of the functional ramifications of the impressive crop of
new structures. A vast number of the genes still have no assigned
function and it is hoped and encouraged that major efforts to
accelerate discovery of function will now follow as a result of the
resounding success in HT gene sequencing and HT structure deter-
mination. The new glimpses into protein-structure evolution and the
insights into structural and functional diversification of proteins that
we have gained through the large-scale protein structure determi-
nation gives us a preview of what further new discoveries could be
unearthed by novel applications of HT structure determination.
We thank all of the members of the JCSG, past and present, for
their work and dedication, which enabled the development and
implementation of our HTSB pipeline. This work was supported by
the NIH, National Institute of General Medical Sciences, Protein
Structure Initiative grants U54 GM074898 and U54 GM094586. The
content is solely the responsibility of the authors and does not
necessarily represent the official views of the National Institute of
General Medical Sciences or the National Institutes of Health.
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